JOIN4ATMP is an EU Horizon-awarded project, that maps, joins and drives European activities to develop and implement the use of ATMPs to the benefit of patients and society. This project brings together top-level ATMP researchers, producers, and clinicians from 14 partners, joining all members of the European University Hospital Alliance (EUHA), and other networks and universities within Europe. Join4ATMP has three clear focus areas, namely: (i) categorizing obstacles to ATMP progress; (ii) mapping potential solutions based on real-world use cases; and (iii) designing actionable recommendations. At Erasmus MC, we will lead standardized Good Manufacturing Practice (GMP)-conform ATMP production. Specifically, the research candidate will: map regulatory criteria as well as organizational and infrastructural requirements for ATMP manufacture; chart guidelines for pharmaceutical-grade raw materials; design criteria for a dynamic regulatory framework as well as work towards a blueprint for an EU-wide GMP unit coordination platform. For more information, please see here.
The Department of Medical Oncology has a long-standing tradition in clinical and translational cancer research. The research activities of our department are organized into 5 different divisions: Translational Cancer Genomics and Proteomics, Translational Pharmacology; Translational Onco-Immunology; Clinical Trials; and Palliative and Supportive Care.
Research at the laboratory of Tumor Immunology (Division of Translational Onco-Immunology) is involved in the following activities towards new or ongoing patient studies: develop and test T cell treatments; understand and intervene with cross-talk between tumor cells and micro-environment; and immune monitor T cell phenotype and function. See
conditions for employment.
Terms of employment Terms of employment
.
No agencies please.
Vacature van Erasmus MC